• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

回顾性分析低分子肝素预防创伤患者静脉血栓栓塞的效果。

A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.

机构信息

Legacy Emanuel Medical Center, 2801 N. Gantenbein, Suite 130, Portland, OR 97227, USA.

Legacy Emanuel Medical Center, 2801 N. Gantenbein, Suite 130, Portland, OR 97227, USA.

出版信息

Am J Surg. 2014 May;207(5):648-51; discussion 651-2. doi: 10.1016/j.amjsurg.2013.12.010. Epub 2014 Jan 30.

DOI:10.1016/j.amjsurg.2013.12.010
PMID:24560359
Abstract

BACKGROUND

In trauma patients, Enoxaparin (a low molecular weight heparin, LMWH) prophylaxis for venous thromboembolism (VTE) risk reduction is unproven.

METHODS

Cohort analysis conducted consisting of all trauma patients age >13 admitted to Level-I trauma center and hospitalized >48 hours. VTE risk determined by the Risk Assessment Profile. High risk patients received LMWH unless contraindicated, while low and moderate risk patients received LMWH at attending surgeon's discretion. Odds ratio for VTE by logistic regression. VTE incidence, relative risk (RR), and number needed to treat (NNT) to prevent deep vein thrombosis (DVT) or pulmonary embolism determined by risk category.

RESULTS

Cohort consisted of 2,281 patients (1,211 low, 979 moderate, 91 high risks). VTE occured in 254 patients (11.1%). High-risk patients had significantly higher VTE incidence, odds ratio = 31.8 (P < .001). VTE was significantly reduced in high-risk patients receiving LMWH versus those who did not (.26 vs .53, P = .02). Among moderate and high risk, prophylactic LMWH reduced the incidence of pulmonary embolism (RR = .19, NNT = 40.4, P = .01), and trended toward reduced DVT incidence (RR = .81, NNT = 27.3, P = .15). LMWH lowered DVT incidence (RR = .52, NNT = 4.1, P = .03) in high risk patients.

CONCLUSION

Prophylactic LMWH is associated with reduction of VTE in trauma patients.

摘要

背景

在创伤患者中,依诺肝素(一种低分子肝素,LMWH)预防静脉血栓栓塞症(VTE)的效果尚未得到证实。

方法

对所有年龄>13 岁、入住一级创伤中心且住院时间>48 小时的创伤患者进行队列分析。VTE 风险通过风险评估模型确定。高危患者除非有禁忌证,否则给予 LMWH 预防,而低危和中危患者则由主治医生决定是否给予 LMWH 预防。采用逻辑回归分析 VTE 的比值比。根据风险类别确定 VTE 发生率、相对风险(RR)和预防深静脉血栓形成(DVT)或肺栓塞的需要治疗人数(NNT)。

结果

队列包括 2281 例患者(低危 1211 例,中危 979 例,高危 91 例)。254 例患者发生 VTE(11.1%)。高危患者 VTE 发生率显著更高,比值比=31.8(P<.001)。与未接受 LMWH 预防的患者相比,接受 LMWH 预防的高危患者 VTE 发生率显著降低(0.26 比 0.53,P=.02)。在中危和高危患者中,预防性 LMWH 降低了肺栓塞的发生率(RR=0.19,NNT=40.4,P=.01),且有降低 DVT 发生率的趋势(RR=0.81,NNT=27.3,P=.15)。LMWH 降低了高危患者的 DVT 发生率(RR=0.52,NNT=4.1,P=.03)。

结论

预防性 LMWH 可降低创伤患者的 VTE 发生率。

相似文献

1
A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.回顾性分析低分子肝素预防创伤患者静脉血栓栓塞的效果。
Am J Surg. 2014 May;207(5):648-51; discussion 651-2. doi: 10.1016/j.amjsurg.2013.12.010. Epub 2014 Jan 30.
2
Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.成年癌症患者群体中静脉血栓栓塞预防措施的回顾性评估。
J Oncol Pharm Pract. 2010 Mar;16(1):27-31. doi: 10.1177/1078155209104379. Epub 2009 Apr 28.
3
Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.内科疾病患者静脉血栓栓塞预防的荟萃分析
Clin Ther. 2007 Nov;29(11):2395-405. doi: 10.1016/j.clinthera.2007.11.015.
4
Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.高危创伤患者使用抗 Xa 因子浓度的达肝素预防方案对静脉血栓栓塞的影响。
J Trauma Acute Care Surg. 2014 Feb;76(2):450-6. doi: 10.1097/TA.0000000000000087.
5
Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.普通肝素与低分子量肝素用于创伤患者静脉血栓栓塞症的预防
J Trauma Acute Care Surg. 2017 Jul;83(1):151-158. doi: 10.1097/TA.0000000000001494.
6
Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.抗Xa因子指导下的依诺肝素血栓预防可降低高危创伤患者深静脉血栓形成的发生率。
J Trauma Acute Care Surg. 2016 Dec;81(6):1101-1108. doi: 10.1097/TA.0000000000001193.
7
Utility of the risk assessment profile for risk stratification of venous thrombotic events for trauma patients.评估风险概况在创伤患者静脉血栓栓塞事件风险分层中的作用。
Am J Surg. 2013 May;205(5):517-20; discussion 520. doi: 10.1016/j.amjsurg.2013.01.022.
8
Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population.静脉血栓栓塞症:神经外科人群中的深静脉血栓形成和肺栓塞。
J Neurosurg. 2011 Jan;114(1):40-6. doi: 10.3171/2010.8.JNS10332. Epub 2010 Sep 3.
9
Retrospective Evaluation of Venous Thromboembolism Prophylaxis in Elderly, High-Risk Trauma Patients.回顾性评估老年、高危创伤患者的静脉血栓栓塞预防。
J Surg Res. 2020 May;249:225-231. doi: 10.1016/j.jss.2019.12.024. Epub 2020 Jan 25.
10
Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.达肝素与依诺肝素用于急性脊髓损伤和重大骨科创伤患者静脉血栓栓塞预防的比较:“DETECT”试验
J Trauma. 2007 May;62(5):1075-81; discussion 1081. doi: 10.1097/TA.0b013e31804fa177.

引用本文的文献

1
Venous thromboembolism chemoprophylaxis after severe polytrauma: timing and type of prophylaxis matter.严重多发伤后的静脉血栓栓塞化学预防:预防的时机和类型至关重要。
Eur J Trauma Emerg Surg. 2024 Dec;50(6):2721-2726. doi: 10.1007/s00068-024-02651-3. Epub 2024 Sep 10.
2
Risk Factors for Deep Venous Thrombosis Following Orthopaedic Trauma Surgery: An Analysis of 56,000 patients.骨科创伤手术后深静脉血栓形成的危险因素:对56000例患者的分析
Arch Trauma Res. 2016 Jan 23;5(1):e32915. doi: 10.5812/atr.32915. eCollection 2016 Mar.